Incidental Mutation 'R5577:Akt2'
ID 437253
Institutional Source Beutler Lab
Gene Symbol Akt2
Ensembl Gene ENSMUSG00000004056
Gene Name thymoma viral proto-oncogene 2
Synonyms PKB, 2410016A19Rik, PKBbeta
MMRRC Submission 043132-MU
Accession Numbers
Essential gene? Probably essential (E-score: 0.908) question?
Stock # R5577 (G1)
Quality Score 225
Status Not validated
Chromosome 7
Chromosomal Location 27290977-27340251 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to A at 27335731 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Glycine to Arginine at position 335 (G335R)
Ref Sequence ENSEMBL: ENSMUSP00000132141 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000051356] [ENSMUST00000085917] [ENSMUST00000108342] [ENSMUST00000108343] [ENSMUST00000108344] [ENSMUST00000136962] [ENSMUST00000167435]
AlphaFold Q60823
Predicted Effect probably damaging
Transcript: ENSMUST00000051356
AA Change: G335R

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000052103
Gene: ENSMUSG00000004056
AA Change: G335R

DomainStartEndE-ValueType
PH 6 110 3.05e-18 SMART
S_TKc 152 409 1.23e-105 SMART
S_TK_X 410 477 1.16e-14 SMART
Predicted Effect probably damaging
Transcript: ENSMUST00000085917
AA Change: G292R

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000083081
Gene: ENSMUSG00000004056
AA Change: G292R

DomainStartEndE-ValueType
PH 6 110 3.05e-18 SMART
Pfam:Pkinase 152 279 4.4e-32 PFAM
Pfam:Pkinase_Tyr 152 279 7.7e-15 PFAM
Pfam:Pkinase_Tyr 276 351 7e-6 PFAM
Pfam:Pkinase 277 366 1.3e-16 PFAM
S_TK_X 367 434 1.16e-14 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000108342
SMART Domains Protein: ENSMUSP00000103979
Gene: ENSMUSG00000004056

DomainStartEndE-ValueType
PH 6 110 3.05e-18 SMART
Pfam:Pkinase 142 222 1.2e-13 PFAM
Predicted Effect probably damaging
Transcript: ENSMUST00000108343
AA Change: G335R

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000103980
Gene: ENSMUSG00000004056
AA Change: G335R

DomainStartEndE-ValueType
PH 6 110 3.05e-18 SMART
S_TKc 152 409 1.23e-105 SMART
S_TK_X 410 477 1.16e-14 SMART
Predicted Effect probably damaging
Transcript: ENSMUST00000108344
AA Change: G335R

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000103981
Gene: ENSMUSG00000004056
AA Change: G335R

DomainStartEndE-ValueType
PH 6 110 3.05e-18 SMART
S_TKc 152 409 1.23e-105 SMART
S_TK_X 410 477 1.16e-14 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000136962
SMART Domains Protein: ENSMUSP00000117682
Gene: ENSMUSG00000004056

DomainStartEndE-ValueType
PH 6 110 3.05e-18 SMART
Pfam:Pkinase 152 229 9.6e-13 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000136981
Predicted Effect probably damaging
Transcript: ENSMUST00000167435
AA Change: G335R

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000132141
Gene: ENSMUSG00000004056
AA Change: G335R

DomainStartEndE-ValueType
PH 6 110 3.05e-18 SMART
S_TKc 152 409 1.23e-105 SMART
S_TK_X 410 477 1.16e-14 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000143347
Coding Region Coverage
  • 1x: 99.9%
  • 3x: 99.7%
  • 10x: 98.6%
  • 20x: 96.2%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygotes for targeted null mutations exhibit insulin resistance and elevated plasma triglycerides. In males, the insulin resistance may progress to overt diabetes. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 36 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
9130023H24Rik A C 7: 127,835,826 (GRCm39) Y256D probably damaging Het
Acr C A 15: 89,458,441 (GRCm39) T374K probably benign Het
Ccn3 T A 15: 54,615,897 (GRCm39) I354N possibly damaging Het
Cd177 A T 7: 24,444,562 (GRCm39) F673Y probably damaging Het
Clmn G T 12: 104,743,329 (GRCm39) S879R probably damaging Het
Csrp3 T C 7: 48,489,225 (GRCm39) H19R possibly damaging Het
Dmkn T C 7: 30,463,971 (GRCm39) S137P probably damaging Het
Eno1 C A 4: 150,331,067 (GRCm39) Y236* probably null Het
Enpp7 T A 11: 118,882,953 (GRCm39) N342K probably benign Het
Fancm T A 12: 65,177,185 (GRCm39) probably benign Het
Fshr A T 17: 89,293,351 (GRCm39) D442E probably benign Het
Gm3898 T A 9: 43,741,362 (GRCm39) noncoding transcript Het
Hdac7 A T 15: 97,709,336 (GRCm39) S43T probably benign Het
Herc1 T C 9: 66,389,263 (GRCm39) C3927R probably damaging Het
Klc4 G T 17: 46,946,355 (GRCm39) A490D probably damaging Het
Lcn9 T A 2: 25,713,663 (GRCm39) I63N probably damaging Het
Lgalsl G A 11: 20,779,316 (GRCm39) Q110* probably null Het
Lrp1b A T 2: 40,765,135 (GRCm39) M2783K possibly damaging Het
Lrrk2 A T 15: 91,649,948 (GRCm39) Y1695F probably damaging Het
Myo1e G A 9: 70,277,753 (GRCm39) E817K probably benign Het
Nav3 A T 10: 109,605,264 (GRCm39) D936E probably damaging Het
Necab3 T C 2: 154,387,076 (GRCm39) probably null Het
Nlrp1a T A 11: 70,990,400 (GRCm39) I951F probably damaging Het
Or5v1 T A 17: 37,810,493 (GRCm39) I317K probably benign Het
Or8b52 A G 9: 38,576,297 (GRCm39) I281T possibly damaging Het
Ppp2r5d T C 17: 46,998,901 (GRCm39) S54G probably benign Het
Prdx6 A G 1: 161,071,255 (GRCm39) S146P probably damaging Het
Sec24a A T 11: 51,625,448 (GRCm39) H258Q probably benign Het
Sec31a T C 5: 100,550,133 (GRCm39) T194A possibly damaging Het
Sqstm1 T C 11: 50,098,266 (GRCm39) I167V probably benign Het
Tas1r3 T C 4: 155,946,522 (GRCm39) E361G probably benign Het
Tlr1 T A 5: 65,083,428 (GRCm39) Q383L possibly damaging Het
Trappc8 G C 18: 20,969,836 (GRCm39) Y1051* probably null Het
Vmn2r2 T A 3: 64,024,416 (GRCm39) M722L probably benign Het
Vmn2r43 T C 7: 8,247,811 (GRCm39) H784R probably damaging Het
Zfp534 T G 4: 147,759,173 (GRCm39) K499Q probably damaging Het
Other mutations in Akt2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01358:Akt2 APN 7 27,335,579 (GRCm39) missense probably damaging 1.00
IGL01981:Akt2 APN 7 27,337,499 (GRCm39) missense probably benign 0.04
IGL02340:Akt2 APN 7 27,328,824 (GRCm39) missense probably damaging 1.00
IGL02794:Akt2 APN 7 27,328,806 (GRCm39) missense probably benign 0.00
Pedunculated UTSW 7 27,336,595 (GRCm39) missense probably benign
perezoso UTSW 7 27,335,483 (GRCm39) missense probably damaging 1.00
Sessile UTSW 7 27,332,666 (GRCm39) missense probably damaging 1.00
Slothful UTSW 7 27,315,774 (GRCm39) missense possibly damaging 0.95
R0013:Akt2 UTSW 7 27,335,483 (GRCm39) missense probably damaging 1.00
R0129:Akt2 UTSW 7 27,336,395 (GRCm39) missense probably damaging 1.00
R0355:Akt2 UTSW 7 27,336,334 (GRCm39) splice site probably benign
R1515:Akt2 UTSW 7 27,336,583 (GRCm39) missense probably damaging 1.00
R2207:Akt2 UTSW 7 27,336,625 (GRCm39) splice site probably null
R2921:Akt2 UTSW 7 27,328,411 (GRCm39) missense probably benign 0.01
R4953:Akt2 UTSW 7 27,337,597 (GRCm39) splice site probably null
R5495:Akt2 UTSW 7 27,335,594 (GRCm39) critical splice donor site probably null
R6494:Akt2 UTSW 7 27,315,774 (GRCm39) missense possibly damaging 0.95
R6987:Akt2 UTSW 7 27,332,666 (GRCm39) missense probably damaging 1.00
R7034:Akt2 UTSW 7 27,336,437 (GRCm39) critical splice donor site probably null
R7036:Akt2 UTSW 7 27,336,437 (GRCm39) critical splice donor site probably null
R7461:Akt2 UTSW 7 27,336,595 (GRCm39) missense probably benign
R7613:Akt2 UTSW 7 27,336,595 (GRCm39) missense probably benign
R8744:Akt2 UTSW 7 27,317,738 (GRCm39) missense probably benign 0.00
Predicted Primers PCR Primer
(F):5'- GCCACATCAAGATCACTGACTTTG -3'
(R):5'- TTTGGGTCCTTCTTCAGCAG -3'

Sequencing Primer
(F):5'- CAAGATCACTGACTTTGGCTTG -3'
(R):5'- TCTTCAGCAGTCCAGCCAG -3'
Posted On 2016-10-26